Dear colleagues,
Have you ever wondered what access to medicines is like in Tajikistan?
We have the pleasure of inviting you to take a look at the WHO/Europe publication on medicines prices and consumption in this Central Asia Republic, which also highlights:
-
Total expenditure on medicines and the portion covered with public funds
-
Essential vs non-essential medicines in consumption structure
-
Role of the local industry
-
Outcomes of economic modelling for pricing of medicines proposed for the first iteration of the positive/reimbursement list and other useful information.
This research was made possible thanks to EU’s co-funding and is part of the advocacy efforts for rolling out a reimbursement system in the country.
Please click one of these links to download the publication:
https://iris.who.int/handle/10665/383652
https://www.who.int/europe/publications/i/item/WHO-EURO-2025-12395-52169-80118
https://www.who.int/tajikistan/publications/i/item/WHO-EURO-2025-12395-52169-80118
Happy reading!
Best regards,
Stanislav Kniazkov